FINWIRES · TerminalLIVE
FINWIRES

HSBC Trims Nahdi Medical PT, Affirms Buy Rating

By

HSBC on Wednesday lowered the price target for retail pharmacy and healthcare company Nahdi Medical (SASE:4164) to 136 Saudi riyals from 140 riyals, while keeping its buy rating.

What else is happening in Research?